Literature DB >> 15790978

Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification.

J J Egan, F J Martinez, A U Wells, T Williams.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15790978      PMCID： PMC1747374          DOI： 10.1136/thx.2004.035436

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  26 in total

1.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 2.  Pulmonary function testing in idiopathic interstitial pneumonias.

Authors:  Fernando J Martinez; Kevin Flaherty
Journal:  Proc Am Thorac Soc       Date:  2006-06

3.  129Xenon Gas Exchange Magnetic Resonance Imaging as a Potential Prognostic Marker for Progression of Idiopathic Pulmonary Fibrosis.

Authors:  Leith J Rankine; Ziyi Wang; Jennifer M Wang; Mu He; H Page McAdams; Joseph Mammarappallil; Craig R Rackley; Bastiaan Driehuys; Robert M Tighe
Journal:  Ann Am Thorac Soc       Date:  2020-01

4.  Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

Authors:  Kevin R Flaherty; Adin-Cristian Andrei; Susan Murray; Chris Fraley; Thomas V Colby; William D Travis; Vibha Lama; Ella A Kazerooni; Barry H Gross; Galen B Toews; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2006-07-06       Impact factor: 21.405

5.  B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.

Authors:  Silvia Bosello; Maria De Santis; Gina Lama; Cristina Spanò; Cristiana Angelucci; Barbara Tolusso; Gigliola Sica; Gianfranco Ferraccioli
Journal:  Arthritis Res Ther       Date:  2010-03-25       Impact factor: 5.156

6.  Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysema.

Authors:  Fushi Dong; Yimei Zhang; Fangzhou Chi; Qi Song; Lijuan Zhang; Yupeng Wang; Chunli Che
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  A retrospective study of the tolerability of nintedanib for severe idiopathic pulmonary fibrosis in the real world.

Authors:  Masayuki Nakamura; Masaki Okamoto; Kiminori Fujimoto; Tomohiro Ebata; Masaki Tominaga; Takashi Nouno; Yoshiaki Zaizen; Shinjiro Kaieda; Tohru Tsuda; Tomotaka Kawayama; Tomoaki Hoshino
Journal:  Ann Transl Med       Date:  2019-06

8.  β-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.

Authors:  Maria De Santis; Rosanna Inzitari; Silvia L Bosello; Giusy Peluso; Chiara Fanali; Federica Iavarone; Gaetano Zizzo; Mario Bocci; Tiziana Cabras; Irene Messana; Leo Fuso; Francesco Varone; Gabriella Pagliari; Massimo Castagnola; Gianfranco Ferraccioli
Journal:  Respir Res       Date:  2011-02-11

Review 9.  The safety of biologic therapies in RA-associated interstitial lung disease.

Authors:  Meghna Jani; Nik Hirani; Eric L Matteson; William G Dixon
Journal:  Nat Rev Rheumatol       Date:  2013-12-24       Impact factor: 20.543

10.  Do we need exercise tests to detect gas exchange impairment in fibrotic idiopathic interstitial pneumonias?

Authors:  Benoit Wallaert; Lidwine Wemeau-Stervinou; Julia Salleron; Isabelle Tillie-Leblond; Thierry Perez
Journal:  Pulm Med       Date:  2012-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.